UK Vaccine Innovation Pathway: A new blueprint for trial delivery

This webinar on September 18th will provide a unique insight into the success of the UK Vaccine Innovation Pathway (VIP). This trailblazing programme of work has created a new blueprint for trial delivery. Inspired by the UK’s unparalleled clinical trial performance during the pandemic, the UK Vaccine Innovation Pathway has transformed and accelerated contract commercial clinical trials in infectious diseases and cancer. Join host Dr Maria Koufali, NIHR Life Sciences Industry Director and previously Head of the UK Vaccine Innovation Pathway, and her panel of experts as they unpack how they delivered vaccine trials at pace and scale.